
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (China), China, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
61%
Total
Publications
387
Total Open
Publications
238
Total
Citations
15K
Open Access
Percentage
61%
Total
Publications
387
Total Open
Publications
238
Total
Citations
15K
Breakdown
Publisher Open
25%
Both
27%
Other Platform Open
9%
Closed
39%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
72
Hybrid 23%
46
No Guarantees 42%
86
Other Platform Open
Domain 68%
97
Institution 43%
62
Other Internet 16%
23
Preprint 8%
12
Public 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 99 |
doaj.org OAI-PMH Repository | Institution | 36 |
DOI | Other Internet | 12 |
Unknown Repository | Other Internet | 11 |
Research Square | Preprint | 7 |
LA Referencia | Institution | 6 |
National Institute of Informatics | Institution | 4 |
University of Birmingham | Institution | 3 |
Yonsei University | Institution | 2 |
White Rose University Consortium | Institution | 2 |